⚠️ Vyvanse is a controlled substance — a valid prescription is required, every time.
Lisdexamfetamine (Vyvanse) is a Schedule I controlled drug under Canada’s Controlled Drugs and Substances Act (CDSA). We cannot and will not dispense Vyvanse without a valid, unexpired prescription from a Canadian-licensed prescriber. Every prescription is verified by our pharmacist — including direct contact with the prescriber where needed. Forged, altered, or expired prescriptions are refused and reported to the appropriate regulatory authority.
About Vyvanse
Vyvanse is the brand name for lisdexamfetamine dimesylate, a once-daily prodrug stimulant manufactured by Takeda. It is approved by Health Canada for the treatment of:
- Attention-Deficit/Hyperactivity Disorder (ADHD) in patients aged 6 and older
- Moderate to severe Binge Eating Disorder (BED) in adults
Lisdexamfetamine is inactive until metabolized in the body, giving it a smoother, longer-acting profile than immediate-release amphetamines. It is taken once in the morning with or without food.
This is educational information only and is not medical advice. Always follow your prescriber’s directions and read the patient leaflet that ships with your medication.
Available strengths
- Capsules: 10 mg · 20 mg · 30 mg · 40 mg · 50 mg · 60 mg · 70 mg
- Chewable tablets: 10 mg · 20 mg · 30 mg · 40 mg · 50 mg · 60 mg
Storage & handling
Store at 15–30 °C in the original child-resistant container. Keep out of reach of children. Return unused or expired capsules to any Canadian pharmacy for safe disposal — never flush.
Why buy Vyvanse
Vyvanse is one of the most widely prescribed stimulants in Canada for ADHD and binge eating disorder because of its once-daily dosing, smoother onset, and lower misuse potential compared with immediate-release amphetamines.
ADHD symptom control
Clinical studies show significant improvement in attention span, impulse control, and hyperactivity in children, adolescents, and adults. Many patients notice benefit within the first week of therapy.
Binge Eating Disorder (BED)
Vyvanse is the only medication in Canada approved specifically for moderate to severe BED in adults. It reduces the number of binge days per week and helps restore healthier eating patterns.
Once-daily convenience
A single morning dose covers school or work hours without the need for mid-day dosing. This improves adherence and reduces the stigma of taking medication in public.
Prodrug design
Lisdexamfetamine is inactive until metabolized in the body. This creates a smoother blood-level curve and a lower peak than mixed amphetamine salts, which many patients tolerate better.
Lower misuse potential
The prodrug formulation makes it difficult to crush, snort, or inject for rapid effect. This safety profile is important for patients, families, and prescribers concerned about diversion.
Flexible strengths
Available from 10 mg up to 70 mg in both capsules and chewable tablets, allowing prescribers to titrate gradually to the lowest effective dose for each individual.
Effects of Vyvanse
Understanding how Vyvanse works and what to expect helps you use it safely and recognize when to contact your prescriber.
How it works
Vyvanse is a prodrug of dextroamphetamine. After oral administration, enzymes in red blood cells convert lisdexamfetamine into active dextroamphetamine. This conversion happens gradually, producing a steady release of active drug over 10–12 hours rather than a sharp spike and crash.
Dextroamphetamine increases the activity of dopamine and norepinephrine in the brain. These neurotransmitters play key roles in attention, motivation, and impulse control — the areas most affected in ADHD and BED.
Therapeutic effects
- Improved focus and sustained attention during school or work tasks
- Reduced impulsive behaviour and interruptions
- Decreased hyperactivity in children and adults
- Fewer binge-eating episodes per week in adults with BED
- Better time management and task completion
Onset and duration
Most patients begin to feel the effects 1–2 hours after taking Vyvanse. Peak concentration typically occurs around 3.5 hours for capsules and slightly earlier for chewable tablets. The therapeutic effect generally lasts 10–12 hours, which is why it is taken once daily in the morning.
Taking Vyvanse later in the day can cause insomnia. If you miss a morning dose, skip it and resume the next day — do not double up.
What to monitor
- Heart rate and blood pressure — report persistent elevation
- Appetite and weight — especially in children and adolescents
- Mood changes — including anxiety, irritability, or low mood
- Sleep quality — difficulty falling or staying asleep
- Growth in children — regular height and weight checks
Your prescriber will typically schedule follow-up appointments every 1–3 months when starting or adjusting Vyvanse to monitor response and side effects.
Usfeul Info
Read our blogs to know more about Vyvanse in Canada, how to use, where to buy and others
Our blog



